Ionis Pharmaceuticals (IONS) Gains from Sales and Divestitures (2013 - 2025)
Ionis Pharmaceuticals (IONS) recorded quarterly Gains from Sales and Divestitures of $1.4 million in Q4 2025, up 16.03% quarter-over-quarter from $1.2 million in Q4 2024, and up 16.03% on a YoY basis from $1.2 million in Q4 2024.
Ionis Pharmaceuticals (IONS) Gains from Sales and Divestitures (2013 - 2025) Analysis & Trends
Ionis Pharmaceuticals' Gains from Sales and Divestitures history runs 13 years deep, the most recent figure standing at $1.4 million for Q4 2025.
- In Q4 2025, Gains from Sales and Divestitures rose 16.03% year-over-year to $1.4 million; the TTM figure through Dec 2025 stood at $1.4 million (up 16.03% YoY), while the FY2025 annual figure was $1.4 million, up 16.03% from the prior year.
- Gains from Sales and Divestitures was $1.4 million for Q4 2025 at Ionis Pharmaceuticals, up from $1.2 million in the prior quarter.
- In the past five years, Gains from Sales and Divestitures ranged from a high of $1.4 million in Q4 2025 to a low of $75000.0 in Q4 2023.
- Historically, Gains from Sales and Divestitures has averaged $885400.0 across 5 years, with a median of $958000.0 in 2022.
- The sharpest annual moves came in 2023 and 2024: Gains from Sales and Divestitures slumped 92.17% in 2023, then surged 1480.0% in 2024.
- A 5-year view of Gains from Sales and Divestitures shows it stood at $834000.0 in 2021, then gained by 14.87% to $958000.0 in 2022, then plunged by 92.17% to $75000.0 in 2023, then soared by 1480.0% to $1.2 million in 2024, then advanced by 16.03% to $1.4 million in 2025.
- The last three Gains from Sales and Divestitures figures came in at $1.4 million (Q4 2025), $1.2 million (Q4 2024), and $75000.0 (Q4 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Ionis Pharmaceuticals | 12.23 Bn | 10.31 Bn | 243.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.38 Mn |
| Dec 31, 2025 | 1.38 Mn |
| Dec 31, 2024 | 1.19 Mn |
| Dec 31, 2024 | 1.19 Mn |
| Dec 31, 2023 | 75,000.00 |
| Dec 31, 2023 | 75,000.00 |
| Dec 31, 2022 | 958,000.00 |
| Dec 31, 2022 | 958,000.00 |
| Dec 31, 2021 | 834,000.00 |
| Dec 31, 2021 | 834,000.00 |
| Dec 31, 2020 | 602,000.00 |
| Dec 31, 2020 | 602,000.00 |
| Dec 31, 2019 | 422,000.00 |
| Dec 31, 2019 | 422,000.00 |
| Dec 31, 2018 | 324,000.00 |
| Dec 31, 2018 | 324,000.00 |
| Dec 31, 2017 | 296,000.00 |
| Dec 31, 2017 | 296,000.00 |
| Dec 31, 2016 | 270,000.00 |
| Dec 31, 2016 | 270,000.00 |